International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-75
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Written informed consent;
PD, according to the MDS criteria;
Age of participants > 30 and < 75 years;
Being fluent in the language in which the scales are applied.
Disqualifiers
None
Trial population
The project population consists of PD patients with and without neuropsychiatric fluctuations attending routine visits to movement disorders clinics in the participant countries. Only patients capable of giving informed consent will be considered for participation in this project.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsGroup A: Patients with neuropsychiatric fluctuations
Group B: Patients without neuropsychiatric fluctuations
Trial outcomes
Primary outcomes
1
NFS score
Time frame
2 weeks (2 assessments in a time span of 2 weeks)2
SPARK score
Time frame
2 weeks (2 assessments in a time span of 2 weeks)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Collaborator
Carlos III Health Institute
Collaborator
Source ClinicalTrials.gov